Sarepta Therapeutics, Inc. (SRPT)
21.03
+0.17
(+0.82%)
USD |
NASDAQ |
Aug 31, 16:00
21.07
+0.04
(+0.19%)
After-Hours: 20:00
Sarepta Therapeutics Cash and Short Term Investments (Quarterly) : 788.49M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 788.49M |
| March 31, 2026 | 653.19M |
| December 31, 2025 | 939.65M |
| September 30, 2025 | 850.99M |
| June 30, 2025 | 800.14M |
| March 31, 2025 | 522.76M |
| December 31, 2024 | 1.355B |
| September 30, 2024 | 1.198B |
| June 30, 2024 | 1.460B |
| March 31, 2024 | 1.391B |
| December 31, 2023 | 1.676B |
| September 30, 2023 | 1.734B |
| June 30, 2023 | 1.861B |
| March 31, 2023 | 1.882B |
| December 31, 2022 | 1.989B |
| September 30, 2022 | 2.072B |
| June 30, 2022 | 1.928B |
| March 31, 2022 | 2.013B |
| December 31, 2021 | 2.116B |
| September 30, 2021 | 1.599B |
| June 30, 2021 | 1.727B |
| March 31, 2021 | 1.738B |
| December 31, 2020 | 1.939B |
| September 30, 2020 | 1.816B |
| June 30, 2020 | 2.061B |
| Date | Value |
|---|---|
| March 31, 2020 | 2.171B |
| December 31, 2019 | 1.125B |
| September 30, 2019 | 1.049B |
| June 30, 2019 | 1.103B |
| March 31, 2019 | 1.344B |
| December 31, 2018 | 1.174B |
| September 30, 2018 | 792.86M |
| June 30, 2018 | 949.14M |
| March 31, 2018 | 1.049B |
| December 31, 2017 | 1.079B |
| September 30, 2017 | 617.63M |
| June 30, 2017 | 300.95M |
| March 31, 2017 | 390.31M |
| December 31, 2016 | 328.54M |
| September 30, 2016 | 405.84M |
| June 30, 2016 | 133.91M |
| March 31, 2016 | 139.85M |
| December 31, 2015 | 203.19M |
| September 30, 2015 | 99.91M |
| June 30, 2015 | 156.89M |
| March 31, 2015 | 166.22M |
| December 31, 2014 | 210.34M |
| September 30, 2014 | 240.02M |
| June 30, 2014 | 283.54M |
| March 31, 2014 | 232.44M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Moderna, Inc. | 5.138B |
| Arrowhead Pharmaceuticals, Inc. | 1.602B |
| ImmunityBio, Inc. | 357.37M |
| X4 Pharmaceuticals, Inc. | 208.55M |
| MapLight Therapeutics, Inc. | 304.72M |